Increased syndecan-4 expression in sera and skin of patients with atopic dermatitis

Syndecan-4 shedding impairs macrovascular angiogenesis in diabetes mellitus

(2016) Ran Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Syndecan-4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes

(2016) Subhamoy Das et al.   Advanced Healthcare Materials

Syndecan-4 Is a Major Syndecan in Primary Human Endothelial Cells In Vitro, Modulated by Inflammatory Stimuli and Involved in Wound Healing

(2015) Tram Thu Vuong et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation

(2015) Tobias Polte et al.   Nature Communications

Syndecan-4: A component of the mechanosensory apparatus of cardiac fibroblasts

(2012) Allen M. Samarel   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis

(2010) Peter M. Elias   Annals of Dermatology

Lysophosphatidylcholine-mediated functional inactivation of syndecan-4 results in decreased adhesion and motility of dendritic cells

(2010) Johannes Bühligen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Depleting Syndecan-4+ T Lymphocytes Using Toxin-Bearing Dendritic Cell-Associated Heparan Sulfate Proteoglycan-Dependent Integrin Ligand: A New Opportunity for Treating Activated T Cell-Driven Disease

(2010) H. Akiyoshi et al.   JOURNAL OF IMMUNOLOGY